The Executive Director level requires deep trial design expertise in autoimmune diseases, mastery of CDISC SDTM/ADaM, SAS/R, and the ability to defend statistical positions in FDA interactions. Hybrid work, with strong leadership impact, awaits the right candidate.
#J-18808-Ljbffr
We would love to welcome a new Executive Director, Biostatistics-Hybrid Autoimmune Trials to our group in South San Francisco, CA, United States.
This opportunity is part of our work in Bio & Pharmacology & Health, Management & Operations.
The advertised compensation is 300.000 - 360.000.
We aim to respond to suitable candidates as soon as possible.
Full responsibilities and requirements are described in the listing above.
Learn more about the Executive Director, Biostatistics-Hybrid Autoimmune Trials role in the description above.
We appreciate your interest in this position.
Join Nkarta,-Inc. and contribute to our ongoing work.